As the Director of Data Science and Digital Health-Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson, Bryan’s responsibilities include leading the digital health strategy for the neurodegeneration portfolio. His goals are to identify clinically meaningful digital biomarkers from biosensors, smartphones, and different types of active and passive data streams to obtain more objective, more continuous about patients and their disease state. There are limitless possibilities to impact the field of neuroscience when you combine digital health technologies with sophisticated data science approaches. Always to improve the lives of patients, caregivers, and their families.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.